Medios AG (ETR:ILM1)

Market Cap	414.72M
Revenue (ttm)	2.01B
Net Income (ttm)	22.03M
Shares Out	25.51M
EPS (ttm)	0.87
PE Ratio	18.68
Forward PE	13.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,087
Average Volume	32,227
Open	15.30
Previous Close	15.34
Day's Range	15.30 - 16.30
52-Week Range	9.98 - 16.30
Beta	1.05
RSI	69.61
Earnings Date	Mar 26, 2026

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 999
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.